Dendritic cells infected with recombinant fowlpox virus vectors are potentand long-acting stimulators of transgene-specific class I restricted T lymphocyte activity
M. Brown et al., Dendritic cells infected with recombinant fowlpox virus vectors are potentand long-acting stimulators of transgene-specific class I restricted T lymphocyte activity, GENE THER, 7(19), 2000, pp. 1680-1689
The identification of dendritic cells (DC) as the major antigen-presenting
cell type of the immune system, combined with the development of procedures
for their ex vivo culture, has opened possibilities for tumour immunothera
py based on the transfer of recombinant tumour antigens to DC. It is antici
pated that the most effective type of response would be the stimulation of
specific, MHC class I restricted cytotoxic T lymphocytes capable of recogni
sing and destroying tumour cells. in order to make this approach possible,
methods must be developed for the transfer of recombinant antigen to the DC
in such a way that they will initiate an MHC class I restricted response.
Here, we demonstrate that murine DC infected with a recombinant fowlpox vir
us (rFWPV) vector stimulate a powerful, MHC class 1 restricted response aga
inst a recombinant antigen. A rFWPV containing the OVA gene was constructed
and used to infect the DC line DC2.4. The infected DC2.4 cells were found
to stimulate the T-T cell hybridoma line RF33.70, which responds specifical
ly to the MHC class I restricted OVA peptide SIINFEKL. The stimulatory abil
ity of the rFWPV-infected DC2.4 cells lasted for at least 72 h after infect
ion and was eventually limited by proliferation of uninfected cells. By com
parison, DC2.4 cells pulsed with synthetic SIINFEKL peptide stimulated RF33
. 70 well initially, but the stimulatory ability had declined to zero by 24
h after pulsing. FWPV infection of DC2.4 up-regulated MHC and costimulator
y molecule expression, rFWPV was also found to infect both immature and mat
ure human DC derived from cord blood CD34' progenitors and express trangene
s for up to 20 days after infection. We conclude that rFWPV shows promise a
s a vector for antigen gene transfer to DC in tumour immunotherapy protocol
s.